Optogenetics Nobel research yields experimental blindness, Alzheimer's treatments

Optogenetics, the Nobel-winning technique for controlling neurons with light, has advanced from basic research to experimental therapies for blindness and Alzheimer's. The report highlights the translational impact of the technique, though clinical efficacy remains unproven. This matters as it signals a maturation of a foundational neuroscience tool into potential clinical applications.